Answers are grounded in this paper and cite their sources.
Demonstrates improved hepatic and renal functions in rats treated with engineered nanobilosomes, suggesting a new approach to metal toxicity recovery.
< 0.05). Hepatic mTOR levels were significantly elevated by 32.4% and 37.5% in the TM/BB-ABL and TM/BB-ABL treated groups, respectively, while renal mTOR levels increased by 39.6% and 42.8% compared with the TM/W group. Likewise, hepatic PI3K levels increased by 37.9% and 47.4%, whereas renal PI3K levels increased by 33.1% and 37.8% in the TM/BB-ABL and TM/BR-ABL-treated groups, respectively, relative to the TM/W group. Engineered albumin-modified nanobilosomes enhanced the antioxidant, anti-inflammatory, anti-apoptotic, and autophagy-modulatory properties of BB and BR for the treatment of toxic metal-induced hepatorenal damage.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: